Tetrahydrofurandiol stimulation of phospholipase A2, lipoxygenase, and cyclooxygenase gene expression and MCF-7 human breast cancer cell proliferation

Environmental Health Perspectives

Volumn 115, Issue 12, 2007, Pages 1727-1731

  Markaverich, Barry M ^a   Crowley, Jan ^b   Rodriquez, Mary ^a   Shoulars, Kevin ^a   Thompson, Trellis ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

And PLA2 gene expression; Breast cancer cells; COX 2; LOX 12; LOX 5; THF diols

Indexed keywords

ARACHIDONIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ENZYME INHIBITOR; ESTRADIOL; FURAN DERIVATIVE; LINOLEIC ACID; LIPOXYGENASE; PHOSPHOLIPASE A2;

ARTICLE; BREAST TUMOR; CELL PROLIFERATION; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ARACHIDONIC ACID; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ENZYME INHIBITORS; ESTRADIOL; FURANS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LINOLEIC ACID; LIPOXYGENASE; PHOSPHOLIPASES A2; POLYMERASE CHAIN REACTION;

EID: 38749145215     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.10659     Document Type: Article

References (35)

1. Badawi A. F, El-Sohemy A, Stephen LL, Ghoshal AK, Archer MC. 1998. The effect of dietary n-3 and n-6 polyunsaturated fatty acids on the expression of cyclooxygenase 1 and 2 and levels of p21ras in rat mammary glands. Carcinogenesis 19(5):905-910.
2. Berthois Y., Katzenellenbogen JA, Katzenellenbogen BS. 1986. Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci USA 83:2496-2500.
3. Brodie A., Lu Q, Long B. 1999. Aromatase inhibitors and their antitumor effects in model systems. Endocr Relat Cancer 6:205-210.
4. Brodie A., Lu Q, Long B, Fulton A, Chen T, Macpherson N, et al. 2001. Aromatase and COX-2 expression in human breast cancers. J Steroid Biochem Mol Biol 79:41-47.
5. Brueggemeier R., Richards J, Joomprabutra S, Bhat A, Whetstone J. 2001. Molecular pharmacology of aromatase and its regulation by endogenous and exogenous agents. J Steroid Biochem Mol Biol 79:75-84.
6. de Souza P, Castillo M, Myers CE. 1997. Enhancement of paclitaxel activity against hormone-refractory prostate cancer cells in vitro and in vivo by quinacrine. Br J Cancer 75(11):1593-1600.
7. Dolan-O'Keefe M, Chow V, Monnier J, Visner GA, Nick HS. 2000. Transcriptional regulation and structural organization of the human cytosolic phospholipase A2 gene. Am J Physiol Lung Cell Mol Physiol 278(4):L649-L657.
8. Durgam V., Fernandes G. 1997. The growth inhibitory effect of conjugated linoleic acid on MCF-7 cells is related to estrogen responsive system. Cancer Letters 116:121-130.
9. Glasgow W., Eling T. 1990. Epidermal growth factor stimulates linoleic acid metabolism in balb/c 3t3 fibroblasts. Mol Pharmacol 38:503-510.
10. Glasgow W., Eling T. 1994. Structure-activity relationship for potentiation of EGF-dependent mitogenesis by oxygenated metabolites of linoleic acid. Arch Biochem and Biophys 311(2):286-292.
11. Jaattela M., Benedict M, Tewari M, Shayman JA, Dixit VM. 1995. Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. Oncogene 10(12):2297-2305.
12. Jiang W. G, Watkins G, Douglas-Jones A, Mansel RE. 2006. Reduction of isoforms of 15-lipoxygenase (15-LOX)-1 and 15-LOX-2 in human breast cancer. Prostaglandins Leukot Essent Fatty Acids 74(4):235-245.
13. Joubert A. M, Panzer A, Bianchi PC, Lottering ML. 2003. The effects of prostaglandin A2 on cell growth, cell cycle status and apoptosis induction in HeLa and MCF-7 cells. Cancer Lett 191(2):203-209.
14. Jump D.B. 2004. Fatty acid regulation of gene transcription. Crit Rev Clin Lab Sci 41(1):41-78.
15. Kachhap S., Dange P, Ghosh S. 2000. Effect of K-6 polyunsaturated fatty acid (linoleic acid) on BRCA1 gene expression in MCF-7 cell line. Cancer Letters 154:115-120.
16. Kim J. H, Hubbard NE, Ziboh V, Erickson KL. 2005. Attenuation of breast tumor cell growth by conjugated linoleic acid via inhibition of 5-lipoxygenase activating protein. Biochim Biophys Acta 1736(3):244-250.
17. Mani S., Reyna A, Alejandro M, Crowley J, Markaverich B. 2005. Disruption of male sexual behavior by tetrahydrofurandiols (THF-diols). Steroids 70:750-754.
18. Markaverich B., Alejandro M, Markaverich D, Zitzow L, Casajuna N., Camarao N, et al. 2002a. Identification of an endocrine disrupting agent from corn with mitogenic activity. Biochem Biophys Res Commun 291:692-700.
19. Markaverich B., Alejandro M, Thompson T, Mani S, Reyna A, Portillo W., et al. 2007. Tetrahydrofurandiols (THF-diols), leukotoxindiols (LTX-diols) and endocrine disruption in rats. Environ Health Perspect 115:702-708.
20. Markaverich B., Crowley J, Alejandro M, Shoulars K, Casajuna N, Mani S., et al. 2005. Leukotoxindiols from ground corncob bedding disrupt estrous cyclicity in rats and stimulate MCF-7 breast cancer cell proliferation. Environ Health Perspect 113:1698-1704.
21. Markaverich B., Mani S, Alejandro M, Mitchell A, Markaverich D, Brown T., et al. 2002b. A novel endocrine-disrupting agent in corn with mitogenic activity in human breast and prostatic cancer cells. Environ Health Perspect 110:169-177.
22. Markaverich B., Shoulars K, Alejandro M. 2006. Nuclear Type II [3H]estradiol binding site ligands: Inhibition of ER-Positive and ER-negative cell proliferation and c-Myc and cyclin D1 gene expression. Steroids 71: 865-874.
23. Markaverich B. M, Gregory RR, Alejandro MA, Clark JH, Johnson GA, Middleditch BS. 1988. Methyl p-hydroxyphenyllactate: an inhibitor of cell proliferation and an endogenous ligand for nuclear type II binding sites. J Biol Chem 263:7203-7210.
24. Natarajan R., Esworthy R, Bai W, Gu J-L. 1997. Increased 12-lipoxygenase expression in breast cancer tissues and cells. Regulation by epidermal growth factor. J Clin Endocrinol Metab 82:1790-1798.
25. Nie D., Krishnamoorthy S, Jin R, Tang K, Chen Y, Qiao Y, et al. 2006. Mechanisms regulating tumor angiogenesis by 12-lipoxygenase in prostate cancer cells. J Biol Chem 281(27): 18601-18609.
26. Nolan R., Danilowicz R, Eling T. 1988. Role of Arachidonic Acid Metabolism in the mitogenic response of BALB/c 3T3 fibroblasts to epidermal growth factor. Mol Pharmacol 33:650-656.
27. Reddy N., Everhart A, Eling T, Glasgow W. 1997. Characterization of 15-lipoxygenase in human breast carcinoma BT-20 cells: stimulation of 13-HODE formation by TGFo/EGF. Biochem Biophys Res Commun 231:111-116.
28. Richards J., Petral T, Brueggemeier R. 2002. Signaling pathways regulating aromatase and cyclooxygenases in normal and malignant breast cells. J Steroid Biochem Mol Biol 80: 203-212.
29. Sonne-Hansen K, Lykkesfeldt AE. 2005. Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line. J Steroid Biochem Mol Biol 93(1):25-34.
30. Thomas W., Coen N, Faherty S, Flatharta CO, Harvey BJ. 2006. Estrogen induces phospholipase A2 activation through ERK1/2 to mobilize intracellular calcium in MCF-7 cells. Steroids 71(3):256-265.
31. Tong W., Ding XZ, Adrian T. 2002. The mechanisms of lipoxygenase inhibitor-induced apoptosis in human breast cancer cells. Biochem Biophys Res Commun 296:942-948.
32. Yamashita J., Ogawa M, Sakai K. 1995. Prognostic significance of three novel biologic factors in a clinical trial of adjuvant therapy for node-negative breast cancer. Surgery 117(6):601-608.
33. Yamashita S., Yamashita J, Ogawa M. 1994. Overexpression of group II phospholipase A2 in human breast cancer tissues is closely associated with their malignant potency. Br J Cancer 69(6):1166-1170.
34. Yamashita S., Yamashita J, Sakamoto K, Inada K, Nakashima Y, Murata K., et al. 1993. Increased expression of membraneassociated phospholipase A2 shows malignant potential of human breast cancer cells. Cancer 71(10):3058-3064.
35. Zhu J., Nozell S, Wang J, Jiang J, Zhou W, Chen X. 2001. p73 cooperates with DNA damage agents to induce apoptosis in MCF7 cells in a p53-dependent manner. Oncogene 20(30):4050-4057.